Source: BioPortfolio

Numerate: Takeda & Numerate Apply Artificial Intelligence to Drug Discovery

NewsNumerate and Takeda enter agreement to generate novel clinical candidates using AIdriven drug discovery.

Read full article »
Numerate's Competitors | Numerate's News | Numerate's Financials
Stay up-to-date with the latest news on Numerate
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Guido Lanza's photo - President & CEO of Numerate

President & CEO

Guido Lanza

CEO Approval Rating

77/100

Read more
Stay up-to-date with the latest news on Numerate